Letter: risk factors and impacts of psychological morbidity in young people with inflammatory bowel disease - authors' reply

被引：0
|
作者：
Brooks, A. J. [1 ]
Rowse, G. [2 ]
Ryder, A. [2 ]
Peach, E. J. [2 ]
Corfe, B. M. [3 ]
Lobo, A. J. [1 ]
机构：
[1] Sheffield Teaching Hosp NHS Fdn Trust, Acad Dept Gastroenterol, Royal Hallamshire Hosp, Sheffield, S Yorkshire, England
[2] Univ Sheffield, Clin Psychol Unit, Dept Psychol, Sheffield, S Yorkshire, England
[3] Sch Med, Mol Gastroenterol Res Grp, Acad Unit Surg Oncol, Dept Oncol, Sheffield, S Yorkshire, England
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2016年 / 44卷 / 04期
关键词：
D O I：
10.1111/apt.13719
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：426 / 426
页数：1
相关论文
共 50 条
  • [21] Letter: irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease - authors' reply
    Diederen, K.
    Hoekman, D. R.
    Benninga, M. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (03) : 309 - 310
  • [22] Letter: Abdominal pain in patients with inflammatory bowel disease in remission - A look beyond psychosocial factors. Authors' reply
    Ardabili, Ashkan Rezazadeh
    Janssen, Laura
    Mujagic, Zlatan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (11-12) : 1250 - 1251
  • [23] Maladaptive decision-making is associated with psychological morbidity in people with Inflammatory Bowel Disease
    Tate, L. Grinsted
    Johnson, L.
    Jones, G.
    Lobo, A.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S438 - S439
  • [24] Letter: fulminant onset complicated inflammatory bowel disease (IBD) - a unique subtype? Authors' reply
    Jayasooriya, Nishani
    Saxena, Sonia
    Pollok, Richard C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (10) : 1194 - 1195
  • [25] Letter: phenotype and natural history of elderly onset inflammatory bowel disease-Authors' reply
    Manosa, M.
    Domenech, E.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (10) : 1421 - 1422
  • [26] Letter: Mendelian randomization --new perspective in inflammatory bowel disease and pancreatic cancer? Authors' reply
    Massironi, Sara
    Vigano, Chiara
    Danese, Silvio
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (01) : 145 - 146
  • [27] Letter: association between COVID-19 and inflammatory bowel disease-Authors' reply
    Hadi, Yousaf
    Kochhar, Gursimran S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (09) : 1228 - 1229
  • [28] Letter: Persisting with persistence-A caution as an outcome measure in inflammatory bowel disease: Authors' reply
    Yiu, Tsz Hong
    Ko, Yanna
    Pudipeddi, Aviv
    Natale, Patrizia
    Leong, Rupert W.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (03) : 427 - 428
  • [29] Letter: inflammatory bowel disease services during the Covid-19 pandemic - authors' reply
    Deputy, Mohammed
    Hart, Ailsa
    Faiz, Omar
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (08) : 1064 - 1064
  • [30] Letter: validated fatigue questionnaires in inflammatory bowel diseases - authors' reply
    Czuber-Dochan, W.
    Norton, C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (03) : 342 - 342
12345